Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara A Wabl

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Future Oncology (London, England)|January 18, 2023
Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer?Bulent Cetin, Chiara A Wabl, Ozge Gumusay
Urologia Internationalis|October 26, 2021
Optimal Treatment for Patients with Oligometastatic Prostate CancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Future Oncology (London, England)|February 9, 2022
CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Critical Reviews in Oncology/Hematology|October 15, 2020
The DNA damaging revolutionBulent Cetin, Chiara A Wabl, Ozge Gumusay
Current Treatment Options in Oncology|March 22, 2022
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management : Optimal Management for Renal Cell Cancer PatientsBulent Cetin, Chiara A Wabl, Ozge Gumusay
Immunotherapy|June 9, 2023
Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkersBulent Cetin, Chiara A Wabl, Ozge Gumusay
Breast Cancer Research and Treatment|October 10, 2023
A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancerOzge Gumusay, Laura A Huppert, Mark Jesus M Magbanua, et al.
The Oncologist|April 11, 2025
A scoping review of clinical communication in cancer care in AfricaRebecca J DeBoer, Chiara A Wabl, Beatrice P Mushi, et al.
Science Advances|February 4, 2021
A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and bloodDianna L Ng, Andrea C Granados, Yale A Santos, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Future Oncology (London, England)|January 18, 2023
Should one use the combination of abiraterone and poly(ADP-ribose) polymerase inhibitors as first-line therapy for all patients with metastatic castration-resistant prostate cancer?Bulent Cetin, Chiara A Wabl, Ozge Gumusay
Urologia Internationalis|October 26, 2021
Optimal Treatment for Patients with Oligometastatic Prostate CancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Future Oncology (London, England)|February 9, 2022
CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancerBulent Cetin, Chiara A Wabl, Ozge Gumusay
Critical Reviews in Oncology/Hematology|October 15, 2020
The DNA damaging revolutionBulent Cetin, Chiara A Wabl, Ozge Gumusay
Current Treatment Options in Oncology|March 22, 2022
Reshaping Treatment Paradigms for Advanced Renal Cell Cancer Patients and Improving Patient Management : Optimal Management for Renal Cell Cancer PatientsBulent Cetin, Chiara A Wabl, Ozge Gumusay
Immunotherapy|June 9, 2023
Advancing immunotherapy in gastroesophageal cancer through rational combinations and biomarkersBulent Cetin, Chiara A Wabl, Ozge Gumusay
Breast Cancer Research and Treatment|October 10, 2023
A phase Ib/II study of eribulin in combination with cyclophosphamide in patients with advanced breast cancerOzge Gumusay, Laura A Huppert, Mark Jesus M Magbanua, et al.
The Oncologist|April 11, 2025
A scoping review of clinical communication in cancer care in AfricaRebecca J DeBoer, Chiara A Wabl, Beatrice P Mushi, et al.
Science Advances|February 4, 2021
A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and bloodDianna L Ng, Andrea C Granados, Yale A Santos, et al.
Pageof 1